UnknownNot Applicable

Severe Cutaneous Adverse Reactions in Thailand

Thailand200 participantsStarted 2014-01

Plain-language summary

The multicenter registry of patients with severe cutaneous adverse reactions among tertiary medical institutes in Thailand to study clinical characteristics, etiologies, therapeutic outcomes, quality of life, and the values of in vitro drug allergy diagnosis for the confirmation of the causative drugs

Who can participate

Age range15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients fulfilled criteria of probable or definite cases of SJS, TEN, DRESS, or AGEP according to RegiSCAR validation criteria as well as patients diagnosed with GBFDE Exclusion Criteria: * Patients later confirmed to have other diagnosis than diseases mentioned above or have no sufficient data for the registry

What they're measuring

Mortality

Timeframe: 1 year

Diagnostic values of in vitro tests for drug allergy diagnosis

Timeframe: 1 year

Trial details

NCT IDNCT02574988

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12

Contact for this trial

Jettanong Klaewsongkram, MD

02-2564152 Jettanong.K@chula.ac.th

View on ClinicalTrials.gov More Steven-Johnson Syndrome trials